Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP903992.RACr6GPEklFbwFjqhdmEoUE3WCRVcLTPj2WVfBKWWs_c0130_assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP903992.RACr6GPEklFbwFjqhdmEoUE3WCRVcLTPj2WVfBKWWs_c0130_provenance.
• NP693212.RAdvfVN93olN6cLSFai-iFeOT5PkLsQyb2gIUmYgapbAk130_assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693212.RAdvfVN93olN6cLSFai-iFeOT5PkLsQyb2gIUmYgapbAk130_provenance.
• NP763286.RAnzawhJcWO9zwUj2pxtX3wyVvnMc6PiKZfSZH1jVRS2k130_assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763286.RAnzawhJcWO9zwUj2pxtX3wyVvnMc6PiKZfSZH1jVRS2k130_provenance.
• NP419491.RAeww7F_Zx2KwCqs1hg9UqeLKjZWDQIFJBA1FO04Lo1RA130_assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419491.RAeww7F_Zx2KwCqs1hg9UqeLKjZWDQIFJBA1FO04Lo1RA130_provenance.
• NP575427.RA6hzTcjeHW8cG-IvkmqsIVF3FRYlQVy1Pb3QPRSoZyuU130_assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575427.RA6hzTcjeHW8cG-IvkmqsIVF3FRYlQVy1Pb3QPRSoZyuU130_provenance.
• NP355480.RAMBG2PV--RMVOsU8O6nqYvymtbkLrM6repi26ZLHMPlY130_assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP355480.RAMBG2PV--RMVOsU8O6nqYvymtbkLrM6repi26ZLHMPlY130_provenance.
• NP306095.RABaice5DyIywN33gbiirnK8x3tXmvZSZo-3wzT_knNcM130_assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306095.RABaice5DyIywN33gbiirnK8x3tXmvZSZo-3wzT_knNcM130_provenance.
• NP641464.RA9ea9cj30w26iWmxyXSARd5hhLnm_gs1ix4KHWlUw61E130_assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641464.RA9ea9cj30w26iWmxyXSARd5hhLnm_gs1ix4KHWlUw61E130_provenance.
• NP600012.RAIV6f5SD0S1F6gIbNGKh3I3mgTa8dkzeNrv9EVqgGDLY130_assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600012.RAIV6f5SD0S1F6gIbNGKh3I3mgTa8dkzeNrv9EVqgGDLY130_provenance.
• NP302758.RA5STrp_N4bVyhSGvxybb3lT81m1TUyiJ0shZniIIIZ7A130_assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302758.RA5STrp_N4bVyhSGvxybb3lT81m1TUyiJ0shZniIIIZ7A130_provenance.
• assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP607328.RA7UWpefdYIS8AdJPDFCA61p9-yx_vRhjfKLAOy4hGO_8130_assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607328.RA7UWpefdYIS8AdJPDFCA61p9-yx_vRhjfKLAOy4hGO_8130_provenance.
• NP607327.RAuEVEKMEI6tKiC3jX0ytZ3Svl0zSNEsoT4mnI0e6wShc130_assertion description "[Nuclear beta-catenin is required for changes in morphology from glandular to morular phenotypes of endometrial carcinoma (Em Ca) cells, with activation of p14(ARF)/p53/p21(Waf1) and alteration of p16(INK4A)/pRb pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607327.RAuEVEKMEI6tKiC3jX0ytZ3Svl0zSNEsoT4mnI0e6wShc130_provenance.